论文部分内容阅读
随着社会人口的老龄化,老年人急性白血病的发生不断增加,其中以急性髓系白血病(AML)多见。老年是急性白血病预后不良因素之一,是血液系统疾病中的高危重症,病死率高。目前老年白血病的发生率约为1/10万,而缓解率约为30%～40%。老年急性白血病治疗效果差,缓解率低,且治疗早期病死率高,存活期短,目前主要问题是如何使老年急
With the aging of the social population, the incidence of acute leukemia in the elderly is increasing, of which acute myeloid leukemia (AML) is more common. Elderly is one of the unfavorable prognostic factors of acute leukemia, which is a high risk and severe disease in blood system diseases with high case fatality rate. At present, the incidence of senile leukemia is about 1/10 million, while the remission rate is about 30% to 40%. Elderly acute leukemia treatment is poor, low response rate, and early treatment of high mortality and short survival, the main problem is how to make the elderly urgent